ATS GUIDELINES Bundle

INSIDE ▶ Introduction ▶ Recommendations ▶ Tables ▶ Figures Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

American Thoracic Society Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/1467089

Contents of this Issue

Navigation

Page 11 of 25

12 Figures ILDs other than IPF Idiopathic interstitial pneumonia (IIP) Autoimmune-ILDs Unclassifiable Myositis b Sjögrens Vasculitis Systemic lupus erythematosus (SLE) Others Eosinophilic a e shaded area ( ) represents the committee's estimate of the proportion of patients with various types of ILD. Note that IPF is not included in the figure because it is excluded from the definition of PPF. e proportion of patients with ILDs other than IPF who manifest PPF is based on the consensus of opinions and the perception of the international committee. ere are no data to provide the exact or estimated proportion of patients manifesting PPF in ILDs, other than IPF. Figure 4. ILD Manifesting PPF Idiopathic pleuroparenchymal fibroelastosis (iPPFE) Idiopathic desquamative interstitial pneumonia (iDIP) Acute interstitial pneumonia (AIP) Cryptogenic organizing pneumonia (COP) Idiopathic lymphoid interstitial pneumonia (iLIP) Systemic sclerosis (SSc) Acute fibrinous and organizing pneumonia (AFOP) Idiopathic non-specific interstitial pneumonia (iNSIP) Rheumatoid arthritis (RA) Mixed connective tissue disease (MCTD)

Articles in this issue

view archives of ATS GUIDELINES Bundle - INSIDE ▶ Introduction ▶ Recommendations ▶ Tables ▶ Figures Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis